Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Interstitial Lung Disease Induced by Targeted Therapy for Non-Small Cell Lung Cancer: A Review of Diagnosis, Workup, and Management

Yuh-Min Chen2,3,4* and Yung-Hung Luo 1,2,3

1Chest Medicine Division of Medicine Department, Fenglin branch, Taipei Veterans General Hospital, Taiwan

2School of Medicine, National Yang-Ming Medical University, Taipei, Taiwan

3Department of Chest Medicine, Taipei Veterans General Hospital, Taiwan

4Taipei Cancer Center, College of Medical Science and Technology, Taipei Medical University, Taiwan, ROC

*Corresponding Author:
Yuh-Min Chen
Department of Chest Medicine
Taipei Veterans General Hospital, 201
Sec. 2, Shih-pai Road, Taipei 112, Taiwan, ROC
Tel: 886-2-28763466
Fax: 886-2-28763466
E-mail: ymchen@vghtpe.gov.tw

Received date: March 02, 2014; Accepted date: April 24, 2014; Published date: April 26, 2014

Citation:Chen YM, Luo YH (2015) Interstitial Lung Disease Induced by Targeted Therapy for Non-Small Cell Lung Cancer: A Review of Diagnosis, Workup, and Management. J Palliat Care Med 5:204. doi:10.4172/2165-7386.1000204

Copyright: ©2015 Chen YM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Targeted therapies are being increasingly used for cancer treatments and had been proven to improve clinical outcomes. Although targeted therapies demonstrate survival benefit in particular patient populations, they may also increase the frequency of treatment-related toxicities and morbidity. The pulmonary toxicities, especially drug induced-interstitial lung disease (ILD), have emerged as critical adverse drug reactions which are potentially fatal.The main managment of targeted therapy-induced ILD includes drug discontinuation and corticosteroid therapy, but no standard guideline for the treatment of targeted therapy-induced ILD was established. Clinical physicians must cautiously weigh the benefits and risks of targeted therapies causing ILD in order to provide optimal treatments and favorable outcomes. Relevant clinical information regarding management of targeted therapy-induced ILD was reviewed in this article.

Keywords

Recommended Conferences
Google Scholar citation report
Citations : 2035

Journal of Palliative Care & Medicine received 2035 citations as per Google Scholar report

Journal of Palliative Care & Medicine peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page
Top